Inventor · disambiguated record
Steven A. Fischkoff
Also filed as: FISCHKOFF STEVEN · FISCHKOFF STEVEN A · FISCHKOFF STEVEN ALAN
14 granted patents·35 pending applications·176 citations·filing 2002–2021
94Inventor score
Files withABBVIE BIOTECHNOLOGY LTD17ABBOTT BIOTECH LTD9CELULARITY INC4ABBOTT LAB S A3ANTHROGENESIS CORP2
Top patents by PatentIndex Score
49 records- 0194US9090689B1Use of TNFα inhibitor for treatment of psoriasisABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Jul 28, 2015·13 cites·21 claims
- 0294US8906373B2Use of TNF-alpha inhibitor for treatment of psoriasisABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Dec 9, 2014·20 cites·9 claims
- 0393US9085620B1Use of TNFα inhibitor for treatment of psoriatic arthritisABBVIE BIOTECHNOLOGY LTD·Filed 2015·Granted Jul 21, 2015·12 cites·30 claims
- 0493US8889135B2Methods of administering anti-TNFα antibodiesFISCHKOFF STEVEN A·Filed 2002·Granted Nov 18, 2014·58 cites·5 claims
- 0592US9017680B2Methods of administering anti-TNFα antibodiesABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Apr 28, 2015·10 cites·4 claims
- 0691US9073987B2Methods of administering anti-TNFα antibodiesABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Jul 7, 2015·9 cites·2 claims
- 0790US9546212B2Methods of administering anti-TNFα antibodiesABBVIE BIOTECHNOLOGY LTD·Filed 2016·Granted Jan 17, 2017·5 cites·24 claims
- 0890US8992926B2Methods of administering anti-TNFα antibodiesABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Mar 31, 2015·8 cites·4 claims
- 0990US8974790B2Methods of administering anti-TNFα antibodiesABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Mar 10, 2015·8 cites·6 claims
- 1090US8911737B2Methods of administering anti-TNFα antibodiesABBVIE BIOTECHNOLOGY LTD·Filed 2014·Granted Dec 16, 2014·8 cites·6 claims
- 1188US7611702B2TNF-alpha blocker treatment for enterocolitis associated with immunostimulatory therapeutic antibody therapyMEDAREX INC·Filed 2006·Granted Nov 3, 2009·12 cites·20 claims
- 1287US8562973B2Treatment of sarcoidosis using placental stem cellsEDINGER JAMES W·Filed 2011·Granted Oct 22, 2013·12 cites·23 claims
- 1374US11180731B2Methods of treating acute myeloid leukemia and multiple myeloma using natural killer cellsCELULARITY INC·Filed 2017·Granted Nov 23, 2021·1 cites·18 claims
- 1474US2020181252A1Methods of administering anti-tnfalpha antibodiesABBVIE BIOTECHNOLOGY LTD·Filed 2020·Application pending·0 cites
- 1568US11696930B2Use of placental stem cells in treatment of acute kidney injuryCELULARITY INC·Filed 2019·Granted Jul 11, 2023·0 cites·11 claims
- 1667US2014286940A1Treatment of tnfalpha related disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Application pending·0 cites
- 1767US2022072063A1Treatment of diabetic peripheral neuropathy using placental cellsCELULARITY INC·Filed 2021·Application pending·0 cites
- 1867US2014186368A1METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIESABBVIE BIOTECHNOLOGY LTD·Filed 2014·Application pending·0 cites
- 1967US2014286941A1Treatment of tnfalpha related disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Application pending·0 cites
- 2067US2008193466A1Treatment of Anemia Using TNFalpha InhibitorsABBOTT BIOTECH LTD·Filed 2008·Application pending·0 cites
- 2167US2014286939A1Treatment of tnfalpha related disordersABBVIE BIOTECHNOLOGY LTD·Filed 2014·Application pending·0 cites
- 2264US2013243763A1TREATMENT OF HIDRADENITIS SUPPURATIVA (HS) USING TNFalpha ANTIBODIESBANERJEE SUBHASHIS·Filed 2013·Application pending·0 cites
- 2363US2013004507A1METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIESABBOTT BIOTECH LTD·Filed 2012·Application pending·0 cites
- 2462US2015368335A1Treatment of tnf-alpha related disordersABBOTT BIOTECH LTD·Filed 2015·Application pending·0 cites
- 2560US2012177596A1METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIESFISCHKOFF STEVEN A·Filed 2011·Application pending·0 cites
- 2660US2015246968A1Methods of administering anti-tnfalpha antibodiesABBVIE BIOTECHNOLOGY LTD·Filed 2015·Application pending·0 cites
- 2760US2015165023A1Methods of administering anti-tnfalpha antibodiesABBVIE BIOTECHNOLOGY LTD·Filed 2015·Application pending·0 cites
- 2860US2015175691A1Methods of administering anti-tnfalpha antibodiesABBVIE BIOTECHNOLOGY LTD·Filed 2015·Application pending·0 cites
- 2958US2004136991A1Treatment of anemia using TNFalpha inhibitorsABBOTT BIOTECH LTD·Filed 2003·Application pending·0 cites
- 3058US2004131614A1Treatment of pulmonary disorders using TNFalpha inhibitorABBOTT BIOTECH LTD·Filed 2003·Application pending·0 cites
- 3158US2004126372A1Treatment of TNFalpha related disordersABBOTT BIOTECH LTD·Filed 2003·Application pending·0 cites
- 3258US2004126373A1Treatment of coronary disorders using TNFalpha inhibitorsABBOTT BIOTECH LTD·Filed 2003·Application pending·0 cites
- 3358US2004151722A1Treatment of metabolic disorders using TNFalpha inhibitorsABBOTT BIOTECH LTD·Filed 2003·Application pending·0 cites
- 3458US2004136990A1Treatment of pain using TNFalpha inhibitorsABBOTT BIOTECH LTD·Filed 2003·Application pending·0 cites
- 3557US2004219142A1Treatment of skin and nail disorders using TNFalpha inhibitorsABBOTT LAB S A·Filed 2003·Application pending·0 cites
- 3657US2013243786A1Treatment of juvenile rheumatoid arthritis (jra)BANERJEE SUBHASHIS·Filed 2003·Application pending·0 cites
- 3757US2004136989A1Treatment of vasculitides using TNFalpha inhibitorsABBOTT LAB S A·Filed 2003·Application pending·0 cites
- 3857US2007202104A1Treatment of spondyloarthropathies using TNFalpha inhibitorsABBOTT LAB S A·Filed 2003·Application pending·0 cites
- 3951US2004009172A1Use of anti-TNFalpha antibodies and another drugFISCHKOFF STEVEN·Filed 2003·Application pending·0 cites
- 4049US2016030488A1Use of placental stem cells in treatment of acute kidney injuryANTRHOGENESIS CORP·Filed 2014·Application pending·0 cites
- 4149US2014219970A1Treatment of sarcoidosis using placental stem cellsANTHROGENESIS CORP·Filed 2013·Application pending·0 cites
- 4246US2007243184A1Prophylaxis and treatment of enterocolitis associated with anti-ctla-4 antibody therapyFISCHKOFF STEVEN·Filed 2006·Application pending·0 cites
- 4346US2003012786A1Use of anti-TNF antibodies as drugs in treating septic disorders of anemic patientsFiled 2002·Application pending·0 cites
- 4446US2006057626A1Assessment of CTLA-4 polymorphisms in CTLA-4 blockade therapyNICHOL GEOFFREY M·Filed 2005·Application pending·0 cites
- 4545US2015050216A1Uses and Compositions for Treatment of PsoriasisWILLIAN MARY KAYE·Filed 2014·Application pending·0 cites
- 4645US2018264048A1Treatment of diabetic peripheral neuropathy using placental cellsCELULARITY INC·Filed 2016·Application pending·0 cites
- 4742US2009214544A1Method of treating cd30 positive lymphomasMEDAREX·Filed 2006·Application pending·0 cites
- 4841US2003206898A1Use of anti-TNFalpha antibodies and another drugFiled 2002·Application pending·0 cites
- 4934US2017290861A1Treatment of diabetic foot ulcer using placental stem cellsANTHROGENESIS CORP·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Steven A. Fischkoff files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →